Skip to main content

The last days of Theranos — the financials were as overhyped as the blood tests

It was the accountants, not the scientists, who were left with no choice but to deliver a bitter pill to the Theranos board: The company had even less money than time.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.